Aug 4, 2026 05:51PM
Jul 28, 2026 05:35AM
Jul 13, 2026 06:46AM
Jun 26, 2026 04:09PM
Jun 18, 2026 04:00PM
Jun 15, 2026 08:01AM
Jun 4, 2026 04:10AM Spyre (SYRE) PT Raised to $115 at Deutsche Bank
Jun 3, 2026 08:03AM
May 5, 2026 04:26PM
May 5, 2026 10:20AM
Apr 13, 2026 04:21PM
Apr 13, 2026 03:10PM
Apr 13, 2026 02:39PM
Apr 13, 2026 12:37PM Spyre (SYRE) PT Raised to $85 at Jefferies
Apr 13, 2026 11:24AM
Apr 13, 2026 10:38AM
Apr 13, 2026 08:45AM
Apr 13, 2026 08:26AM
Apr 13, 2026 08:21AM
Apr 13, 2026 07:57AM
Apr 13, 2026 07:54AM Mizuho on Spyre (SYRE): 'We see these results as an extremely favorable outcome'
Apr 13, 2026 07:46AM
Apr 13, 2026 07:00AM
Apr 13, 2026 06:56AM
Mar 31, 2026 05:18AM
Mar 18, 2026 07:32AM
Mar 16, 2026 11:33AM
Mar 16, 2026 10:39AM Guggenheim on Spyre Therapeutics (SYRE): 'remains one of our Top 2026 Picks'
Feb 19, 2026 04:35PM
Jan 12, 2026 08:04AM
Dec 17, 2025 04:04PM
Dec 17, 2025 05:02AM
Dec 1, 2025 12:33AM
Nov 5, 2025 07:29AM
Nov 4, 2025 05:50PM Spyre Therapeutics, Inc. (SYRE) Tops Q3 EPS by 62c
Oct 13, 2025 04:41PM
Oct 7, 2025 05:55AM
Sep 26, 2025 03:27AM
Aug 18, 2025 06:13AM
Aug 6, 2025 03:16AM
Jun 17, 2025 07:30AM
Jun 4, 2025 06:23AM Leerink Partners Reiterates Outperform Rating on Spyre (SYRE)
Jun 3, 2025 06:20AM
May 8, 2025 04:17PM
Mar 28, 2025 05:24AM
Mar 18, 2025 04:37AM
Mar 7, 2025 04:43PM
Feb 27, 2025 04:34PM
Feb 27, 2025 04:17PM Spyre Therapeutics, Inc. (SYRE) Tops Q4 EPS by 22c
Dec 3, 2024 06:36AM

446,732 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All